Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butrans for Restless Legs Syndrome
NCT02138357Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of v1003 in restless legs syndrome (RLS), sponsored by Massachusetts General Hospital. Planned start Apr 2014; status: withdrawn.
02
Drugs
v1003
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02138357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138357.